Methods This retrospective, database study used Optums de-identified Clinformatics Data Mart Database to identify glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment-nave adult patients with type 2 diabetes (T2D) initiating semaglutide QW, dulaglutide, liraglutide, or exenatide QW between January 1, 2018 and April 30, 2019
Drugs In the Clinical Phase There are 76 single-target GLP-1R drugs currently in clinical phase 1, 2 and 3 in the world, of which 26 are in clinical phase 3, 2 are in phase 2, 15 are in phase 2, 1 is in phase 1/2, and 32 are in phase 1
95% CI: 0.321.00), though no significant effect was found on all-cause mortality (HR 0.81
Ozempics weight loss benefits stem primarily from appetite suppression